{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:56:38Z","timestamp":1768517798860,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Banco Nacional de Desenvolvimento Econ\u00f4mico e Social","award":["14.2.0914.1"],"award-info":[{"award-number":["14.2.0914.1"]}]},{"name":"National Institute of Science and Technology on Tuberculosis"},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["404440\/2016-9"],"award-info":[{"award-number":["404440\/2016-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FAPERGS-CAPES"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.tube.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T10:50:16Z","timestamp":1517568616000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Effect of the bradykinin 1 receptor antagonist SSR240612 after oral administration in Mycobacterium tuberculosis-infected mice"],"prefix":"10.1016","volume":"109","author":[{"given":"Valn\u00eas S.","family":"Rodrigues-Junior","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla B.","family":"Pail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne D.","family":"Villela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virg\u00ednia C.A.","family":"Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ad\u00edlio S.","family":"Dadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno L.","family":"Abbadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o B.","family":"Pesquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di\u00f3genes S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz A.","family":"Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1153-3633","authenticated-orcid":false,"given":"Maria M.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2018.01.003_bib1","series-title":"Global tuberculosis report 2016","author":"WHO","year":"2016"},{"key":"10.1016\/j.tube.2018.01.003_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.tips.2006.10.007","article-title":"Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain","volume":"27","author":"Campos","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.tube.2018.01.003_bib3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1084\/jem.192.9.1289","article-title":"Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors","volume":"192","author":"Scharfstein","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.tube.2018.01.003_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-12-385895-5.00005-0","article-title":"Infection-associated vasculopathy in experimental Chagas Disease: pathogenic roles of endothelin and kinin pathways","volume":"76","author":"Scharfstein","year":"2011","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.tube.2018.01.003_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1756-3305-5-261","article-title":"Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors","volume":"5","author":"Nico","year":"2012","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.tube.2018.01.003_bib6","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.4049\/jimmunol.1302417","article-title":"C5a and bradykinin receptor cross-talk regulates innate and adaptative immunity in Trypanosoma cruzi infection","volume":"193","author":"Schmitz","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2018.01.003_bib7","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1371\/journal.ppat.0030185","article-title":"Bradykinin B2 Receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses","volume":"3","author":"Monteiro","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2018.01.003_bib8","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2006-04-016444","article-title":"Kinin receptor expression during Staphylococcus aureus infection","volume":"108","author":"Bengtson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tube.2018.01.003_bib9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1124\/jpet.109.155762","article-title":"In vivo up-regulation of kinin B1 receptors after treatment with Porphyromonas gingivalis lipopolysaccharide in rat paw","volume":"330","author":"Dornelles","year":"2009","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.tube.2018.01.003_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005952","article-title":"The kallikrein-kinin system: a novel mediator of IL-17 driven anti-Candida immunity in the kidney","volume":"12","author":"Ramani","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2018.01.003_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1515\/hsz-2015-0206","article-title":"Acute hypothalamo-pituitary-adrenal axis response to LPS-induced endotoxemia: expression pattern of kinin type B1 and B2 receptors","volume":"397","author":"Qadri","year":"2016","journal-title":"Biol Chem"},{"key":"10.1016\/j.tube.2018.01.003_bib12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.bjp.0700914","article-title":"The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG)","volume":"120","author":"Campos","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.tube.2018.01.003_bib13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1517\/17460441.2012.729038","article-title":"Discovery and therapeutic potential of kinin receptor antagonists","volume":"7","author":"Whalley","year":"2012","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.tube.2018.01.003_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/00365548.2014.969304","article-title":"Severe Puumala virus infection in a patient with lymphoproliferative disease treated with icatibant","volume":"47","author":"Laine","year":"2015","journal-title":"Infect Dis"},{"key":"10.1016\/j.tube.2018.01.003_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/infdis\/jiv426","article-title":"Kinin B1 receptor inhibition with BI113823 reduces inflammatory response, mitigates organ injury, and improves survival among rats with severe sepsis","volume":"213","author":"Murugesan","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2018.01.003_bib16","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.tube.2016.09.022","article-title":"Predictive value of serum bradykinin and desArg9-bradykinin levels for chemotherapeutic responses in active tuberculosis patients: a retrospective case series","volume":"101","author":"Qian","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2018.01.003_bib17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/jcbfm.2010.220","article-title":"National centre for the replacement, refinement and reduction of animals in research. Animal research: reporting in vivo experiments\u2013the ARRIVE guidelines","volume":"31","author":"Kilkenny","year":"2011","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.tube.2018.01.003_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijantimicag.2012.04.019","article-title":"Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection","volume":"40","author":"Rodrigues-Junior","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2018.01.003_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijantimicag.2016.04.029","article-title":"Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection","volume":"48","author":"Rodrigues-Junior","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2018.01.003_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11060-014-1549-4","article-title":"Mechanisms involved in kinin-induced glioma cells proliferation: the role of ERK1\/2 and PI3K\/Akt pathways","volume":"120","author":"Nicoletti","year":"2014","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.tube.2018.01.003_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijantimicag.2013.08.021","article-title":"IQG-607 abrogates the synthesis of mycolic acids and displays intracellular activity against in infected Mycobacterium tuberculosis macrophages","volume":"43","author":"Rodrigues-Junior","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2018.01.003_bib22","article-title":"Primary role for kinin B1 and B2 receptors in glioma proliferation","author":"Nicoletti","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.tube.2018.01.003_bib23","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/HYPERTENSIONAHA.107.108506","article-title":"Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors","volume":"51","author":"Duka","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.tube.2018.01.003_bib24","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1073\/pnas.0701617104","article-title":"Bradykinin B1 and B2 receptors both have protective roles in renal ischemia\/reperfusion injury","volume":"104","author":"Kakoki","year":"2007","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.tube.2018.01.003_bib25","doi-asserted-by":"crossref","first-page":"F1249","DOI":"10.1152\/ajprenal.00501.2007","article-title":"Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db\/db mice model","volume":"294","author":"Bul\u00e9on","year":"2008","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.tube.2018.01.003_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.coph.2008.11.011","article-title":"The kinin B1 receptor and inflammation: new therapeutic target for cardiovascular disease","volume":"9","author":"Duchene","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.tube.2018.01.003_bib27","doi-asserted-by":"crossref","first-page":"G361","DOI":"10.1152\/ajpgi.00369.2004","article-title":"Immunolocalization and expression of kinin B1R and B2R receptors in human inflammatory bowel disease","volume":"289","author":"Stadnicki","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979217302238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979217302238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T04:38:37Z","timestamp":1565325517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979217302238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":27,"alternative-id":["S1472979217302238"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2018.01.003","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the bradykinin 1 receptor antagonist SSR240612 after oral administration in Mycobacterium tuberculosis-infected mice","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}